3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Terminated
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Genitourinary
1
Conditions
Cardiotoxicity
2
Breast Neoplasms
2
Renal Insufficiency, Chronic
1
Kidney Neoplasms
1
Heart Failure
1
Carcinoma, Renal Cell
1
Interventions
venetoclax
1
saponin QA-21V1
1
finerenone
1
empagliflozin
1
Surveys and Questionnaires
1
Stem Cell Transplantation
1
Standard of Care
1
Specimen Handling
1
Resistance Training
1
Quillaja Saponins
1
Protein Subunit Vaccines
1
Practice Guidelines as Topic
1
Phlebotomy
1
Kidney Transplantation
1
High-Energy Shock Waves
1
Eplerenone
1
Endurance Training
1
Breathing Exercises
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Renal Insufficiency, Chronic
×
empagliflozin
×
1 year
×
Clear all
NCT06818305
2025-12-11
EmFin-Nx
Jinling Hospital, China
Phase 2
Terminated
10 enrolled